NO985974D0 - Piperidinedacetic acid derivatives and their use in the treatment of thrombosis diseases - Google Patents

Piperidinedacetic acid derivatives and their use in the treatment of thrombosis diseases

Info

Publication number
NO985974D0
NO985974D0 NO985974A NO985974A NO985974D0 NO 985974 D0 NO985974 D0 NO 985974D0 NO 985974 A NO985974 A NO 985974A NO 985974 A NO985974 A NO 985974A NO 985974 D0 NO985974 D0 NO 985974D0
Authority
NO
Norway
Prior art keywords
piperidinedacetic
treatment
acid derivatives
thrombosis diseases
thrombosis
Prior art date
Application number
NO985974A
Other languages
Norwegian (no)
Other versions
NO985974L (en
Inventor
David George Allen
Colin David Eldred
Brian David Judkins
William Leonard Mitchell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO985974D0 publication Critical patent/NO985974D0/en
Publication of NO985974L publication Critical patent/NO985974L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO985974A 1996-06-21 1998-12-18 Piperidinedacetic acid derivatives and their use in the treatment of thrombosis diseases NO985974L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
GB9703196 1997-06-19

Publications (2)

Publication Number Publication Date
NO985974D0 true NO985974D0 (en) 1998-12-18
NO985974L NO985974L (en) 1999-02-17

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985974A NO985974L (en) 1996-06-21 1998-12-18 Piperidinedacetic acid derivatives and their use in the treatment of thrombosis diseases

Country Status (17)

Country Link
EP (1) EP0912555A1 (en)
JP (1) JP2000512648A (en)
KR (1) KR20000022041A (en)
AP (1) AP9801417A0 (en)
AR (1) AR008245A1 (en)
AU (1) AU3261197A (en)
BR (1) BR9709930A (en)
CA (1) CA2258753A1 (en)
CZ (1) CZ424698A3 (en)
EA (1) EA199801015A1 (en)
ID (1) ID17052A (en)
IL (1) IL127464A0 (en)
IS (1) IS4924A (en)
NO (1) NO985974L (en)
PL (1) PL330797A1 (en)
TR (1) TR199802665T2 (en)
WO (1) WO1997049699A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
WO2003004488A1 (en) 2001-07-03 2003-01-16 Chiron Corporation Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
TW200401641A (en) * 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
RU2347780C2 (en) * 2003-02-14 2009-02-27 Уайт Heterocyclyl-3-sulfonylindazoles as 5-hyroxytryptamine-6 ligands
MX2008012824A (en) 2006-04-05 2008-10-15 Wyeth Corp Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands.
KR101132577B1 (en) 2007-01-10 2012-04-05 에프. 호프만-라 로슈 아게 Sulfonamide derivatives as chymase inhibitors
CN113655155A (en) * 2021-07-28 2021-11-16 任贤金 Method for measuring SPH3127 related substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (en) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
TW221996B (en) * 1991-11-14 1994-04-01 Glaxo Group Ltd
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
AR008245A1 (en) 1999-12-29
KR20000022041A (en) 2000-04-25
IS4924A (en) 1998-12-15
BR9709930A (en) 1999-08-10
JP2000512648A (en) 2000-09-26
CZ424698A3 (en) 1999-05-12
EP0912555A1 (en) 1999-05-06
NO985974L (en) 1999-02-17
ID17052A (en) 1997-12-04
WO1997049699A1 (en) 1997-12-31
AU3261197A (en) 1998-01-14
CA2258753A1 (en) 1997-12-31
TR199802665T2 (en) 1999-03-22
EA199801015A1 (en) 1999-08-26
AP9801417A0 (en) 1998-12-31
PL330797A1 (en) 1999-06-07
IL127464A0 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
NO994014D0 (en) Arylsulfonamides and analogs thereof and their use in the treatment of neurodegenerative diseases
NO972972L (en) Compositions for the treatment of dermatological disorders and methods for their use
NO20004098D0 (en) Methods and preparations for the treatment of macrophage-mediated disorders
NO992641D0 (en) Mixtures and Methods for the Treatment or Prevention of Inflammatory Diseases
NO20032695L (en) Carboxamide derivatives and their use in the treatment of thromboembolic diseases
BR9406209A (en) Heterocyclic derivatives in the treatment of ischemia and related diseases
NO20005387D0 (en) 3- (amino or aminoalkyl) pyridinone derivatives and their use in the treatment of HIV-related diseases
NO20001754L (en) Prostaglandin agonists and their use in the treatment of bone disorders
NO994778L (en) Methods and Preparations for the Treatment of Inflammatory Bowel Syndrome
NO941679D0 (en) Bile acid derivatives, methods of preparation and their use
NO995095D0 (en) Substituted imidazoles useful in the treatment of inflammatory diseases
DE69509650D1 (en) TREATMENT OF ATRIAL FIBRILLATIONS
NO20022680L (en) Pharmaceutical combinations and their use in the treatment of gastrointestinal disorders
NO992770D0 (en) Novel heterocyclic substituted benzamides and their use in combating diseases
NO20001412D0 (en) Compositions and Methods in the Treatment of Respiratory Disorders
NO984836D0 (en) Substituted benzylamines and their use in the treatment of depression
NO972426D0 (en) Method for the use of triarylethylene derivatives in the treatment and prevention of osteoporosis
NO20020031D0 (en) Dihydrobenzodiazepines and their use in the treatment of dyslipidemia
DE69841550D1 (en) TREATMENT OF FIBROMYALGIA AND RELATED DISEASES
NO20032340D0 (en) Substituted derivatives of aminofuran-2-yl acetic acid and aminothien-2-yl acetic acid and their use in the treatment of migraine and pain
NO985974D0 (en) Piperidinedacetic acid derivatives and their use in the treatment of thrombosis diseases
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
NO994426D0 (en) New carboxylic acid derivatives, their preparation and use in the treatment of cancer
NO954175D0 (en) Use of vWF-containing concentrates as combination therapy in antithrombotic and fibrinolytic therapy
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application